GlaxoSmithKline Nigeria Plc released its financial results for nine months ended September 2015.

The result showed that revenue declined by 24.51% from N30.5 billion in Q3’2014 to N23 billion in Q3’2015.

Profit before tax also declined by 74.51% from N2.7 billion in Q3’2014 to N700 million in Q3’2015.

See Summary of result below..

GlaxoSmithkline Nigeria Plc Q3 2015 2015 2014 % Change
N’m N’m
Revenue 23,040 30,521 -24.51%
Gross Profit 7,407 10,735 -31.00%
Operating Expenses -2,511 -3,039 -17.37%
Pre-tax profits 700 2,752 -74.56%
Profit After Tax 485 1,848 -73.76%
Share Price (As at Press time)  38.20



Business day


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.